Aseptic processing areas arc deficient regarding the system for cleaning and disinfecting the room and equipment to produce asepuc condit•ons.
Inspection Record
PharMEDium Services, LLC — FDA 483 Findings
Inspectors Camerson E. Moore · Jason R. Caballero · Stephen D. BrownThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Testing and release of drug product for distribution do not include app ropriate laboratory determination ofsatisfactory conformance to the identity and strength of each active ingred ient prior to release.
The batch production and control records are deficient in that they do not include specimen and copy of labeling.
Laboratory controls do not include the establishment of scientifically sound and appropriate specifications and test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.
Procedures designed to prevent microbiological contamination ofdrug products purporting to be sterile are not followed.
The labels of your ou tsou rcing facility's drug products are deficient.
Each batch or drug product purporting to be sterile and pyrogen-free is not laboratory tested 10 determine conformance to such requ irements.
About this record
Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
